Moleculin Biotech Inc. (MBRX)
Market Closed
14 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
LSE $
0. 78
+0.06
+8.4196%
$
3.79M Market Cap
- P/E Ratio
- Div Yield
717,312 Volume
-0.87 Eps
$ 0.71
Previous Close Investors:
Want to track MBRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Moleculin Biotech Inc. (MBRX) Statistics
Valuation metrics
Market Cap 3.79M
Enterprise value -3.15M
Trailing P/E (ttm) -0.04
Forward P/E -0.02
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.35
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.1
Overview
Shares outstanding 3.2M
Float 5.29M
Shares short 113.91K
% Held by insiders 0.01%
% Held by institutions 0.03%
Average volume (10 days) 868.92K
Average volume (90 days) 2.22M
Price summary
52-Week low 0.16
52-Week high 15.75
Beta 1.67
50-Day moving average 0.64
200-Day moving average 2.14
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0.06
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 1 Dec 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.44%
Return on equity -8.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -25.01M
Net income to common (ttm) -33.66M
Diluted EPS (ttm) -5.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 8.88M
Total cash per share (mrq) 1.28
Total debt (mrq) 359K
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 0.94%
Book value per share (mrq) 2.04
Cash Flow
Cash flow statement -22.73M
Levered free cash flow (LFCF) -12.26M
